Kevin D. Bunker - Feb 10, 2022 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Kevin D. Bunker
Stock symbol
ZNTL
Transactions as of
Feb 10, 2022
Transactions value $
-$770,633
Form type
4
Date filed
2/14/2022, 08:11 PM
Previous filing
Jan 20, 2022
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Award $0 +22.5K +3.01% $0.00 769K Feb 10, 2022 Direct F1
transaction ZNTL Common Stock Sale -$123K -2.37K -1.31% $52.15 178K Feb 10, 2022 See Footnote F2, F3, F4
transaction ZNTL Common Stock Sale -$164K -3.07K -1.73% $53.19 175K Feb 10, 2022 See Footnote F2, F4, F5
transaction ZNTL Common Stock Sale -$180K -3.32K -1.9% $54.20 171K Feb 10, 2022 See Footnote F2, F4, F6
transaction ZNTL Common Stock Sale -$68.1K -1.24K -0.72% $54.96 170K Feb 10, 2022 See Footnote F2, F4, F7
transaction ZNTL Common Stock Sale -$81.4K -1.62K -0.21% $50.16 767K Feb 14, 2022 Direct F8, F9
transaction ZNTL Common Stock Sale -$10.3K -203 -0.03% $50.75 767K Feb 14, 2022 Direct F8, F10
transaction ZNTL Common Stock Sale -$144K -2.86K -0.37% $50.29 764K Feb 14, 2022 Direct F2, F11
holding ZNTL Common Stock 350 Feb 10, 2022 As UTMA custodian for sons

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZNTL Stock Option (Right to Buy) Award $0 +52.7K $0.00 52.7K Feb 10, 2022 Common Stock 52.7K $52.61 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.
F2 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $51.68 to $52.67. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.
F5 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $52.69 to $53.68. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $53.71 to $54.68. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $54.72 to $55.41. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
F9 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.58 to $50.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.58 to $50.81. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.97 to $50.69. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F12 The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.